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Background:  We sought to examine our institution’s experience over 4 decades with the Fontan operation, and to determine factors 
associated with morbidity and mortality.
methods:  Records of all patients who had a Fontan from 1973 - 2012 at Mayo Clinic were reviewed. A follow-up questionnaire was mailed 
to all patients known to not be deceased at the time of study.
results:  1052 pts had a Fontan operation (mean age = 9.4 ± 7.5 yrs). 616 pts had an atriopulmonary connection, 262 lateral tunnels, 
120 extracardiac conduits, and 54 had other modifications. Fenestration was performed in only 86 pts (8%). Anatomy included Tricuspid 
Atresia (273), DILV (271), Heterotaxy (135), PA/IVS (55), and HLHS (24). The overall 10, 20, and 30-year survival was 75%, 62%, and 
47%, respectively. Factors associated with decreased long-term survival include: preop diuretic use, asplenia, longer bypass time, postop 
Fontan pressure > 20 mmHg, elevated postop LA pressure, and operation prior to 1990. There was no mortality difference between 
patients with RV and LV dominant ventricular morphology. Preop and post bypass sinus rhythm was associated with improved long-term 
survival. Ten-year survival was improved in patients undergoing extracardiac conduit or lateral tunnel Fontan compared to patients who had 
atriopulmonary connection (p<0.04), though this was influenced by surgical era. Freedom from death or reoperation at 10, 20, and 30 years 
after the Fontan was 70%, 51%, and 37%, respectively. The most common re-operations were pacemaker insertion/revision in 212 patients 
(20%), Fontan revision/conversion in 117 patients (11%) and AV-valve repair/replacement in 66 patients (5%). Clinically significant atrial or 
ventricular arrhythmias occurred in 468 (44%) pts. 95 (9%) pts developed PLE, and 38 (4%) pts had cardiac transplantation.
Conclusion:  As the surgical techniques for the Fontan operation have improved over the last 40 years, there has been improvement 
in survival. However, the development of PLE and arrhythmias, and the need for reoperation during long-term follow-up pose significant 
management challenges.
